Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeActive in the last 2 years

Lili Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6969-8908; OpenAlex author ID A5014059213. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2016: 1 paper · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Single-cell Sequencing Analysis Reveals Cell Subtypes With High Expression of Coagulation Factor 3 and Their Possible Roles in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.31083/fbl44029↗
  2. PD-L1 in pancreatic ductal adenocarcinoma: a retrospective analysis of 373 Chinese patients using an in vitro diagnostic assay. Co-author DOI 10.1186/s13000-017-0678-4↗
  3. Expression of signaling adaptor proteins predicts poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13000-017-0633-4↗
  4. Expression of amphiregulin predicts poor outcome in patients with pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13000-016-0512-4↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jun Ma · 1 shared paper, 2025 · strength 0.27
  2. Chunyan Wang · 1 shared paper, 2025 · strength 0.27
  3. Huanwen Wu · 3 shared papers, 2016–2018 · strength 0.22
  4. Junliang Lu · 3 shared papers, 2016–2018 · strength 0.22
  5. Zhiyong Liang · 3 shared papers, 2016–2018 · strength 0.22
  6. Tonghua Liu · 2 shared papers, 2017–2018 · strength 0.16
  7. Li Wang · 2 shared papers, 2016–2017 · strength 0.14
  8. Xiaolong Liang · 1 shared paper, 2018 · strength 0.08
  9. Jian Hua Sun · 1 shared paper, 2018 · strength 0.08
  10. Zhiwen Zhang · 1 shared paper, 2018 · strength 0.08
  11. Junchao Guo · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.